Bing

SEARCH HISTORY

Trade-Ideas LLC identified BioDelivery Sciences International ( BDSI) as a weak on high relative volume candidate. In addition to specific proprietary factors, Trade-Ideas identified BioDelivery Sciences International as such a stock due to the following ...
The Street · 20 hours ago
High Volume
In-depth coverage >
The news sent BDSI stock soaring more than 44% in Friday morning trading. BDSI stock was boosted by early results from testing of BEMA buprenorphine. Patients in the trial receiving the drug reported significantly more relief from chronic pain compared to ...
Investor Place · ByChristopher Freeburn · 1/24/2014
BioDelivery Sciences International (NASDAQ:BDSI) Director Francis E. Odonnell, Jr. sold 21,597 shares of the stock in a transaction dated Tuesday, June 16th. The stock was sold at an average price of $8.03, for a total transaction of $173,423.91.
Mideast Times · 6/19/2015
More from Bing News
BioDelivery Sciences International, Inc. ( BDSI) saw a big move last session, as the company's shares fell by about 11% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues …
NASDAQ · 12/16/2014
On Monday, shares of pain drug stock BioDelivery Sciences International, Inc (NASDAQ: BDSI) were jumping higher after announcing positive top-line phase 3 results showing that a drug they are developing met its primary endpoint of a statistically ...
Smallcap Network · ByJohn Udovich · 7/8/2014
BioDelivery Sciences International, Inc. (BDSI) saw a big move last session, as the company’s shares fell by over 24% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the ...
Yahoo Finance · 3/31/2015
BioDelivery Sciences International (NASDAQ:BDSI) CEO Mark A. Sirgo sold 4,187 shares of BioDelivery Sciences International stock on the open market in a transaction dated Tuesday, June 16th. The stock was sold at an average price of $7.97, for a total ...
sleekmoney.com · 6/18/2015
Top losers include Merus Labs International Inc (NASDAQ:MSLI), BioDelivery Sciences International (NASDAQ:BDSI), Quidel Corporation (NASDAQ:QDEL). Merus Labs International Inc (NASDAQ:MSLI) fell -4.88%. Shares of BioDelivery Sciences …
Stockhouse · 5/25/2015
What does the smart money think about BioDelivery Sciences International, Inc. (NASDAQ:BDSI)? Heading into Q3, a total of 8 of the hedge funds we track held long positions in this stock, a change of -11% from the previous quarter. With the smart …
INSIDER MONKEY · 9/17/2013
BioDelivery Sciences International (NASDAQ:BDSI ... commented on the stock. Analysts at Cantor Fitzgerald reiterated a “buy” rating and set a $12.00 price target (down previously from $17.00) on shares of BioDelivery Sciences International in a ...
wkrb13.com · 6/18/2015